CD1-MR1 2015*
Chairs: Richard Blumberg & Olivier Lantz
Mechanisms of CD1d-dependent mucosal inflammation in intestines (#39)
3:45 PM
Progress in development of iNKT cell therapeutics based on synthetic analogues of α-galactosyl ceramides (#40)
4:10 PM
The role of group 1 CD1-restricted T cells in infectious and inflammatory diseases (#41)
4:35 PM
Nonclassical MHC-restricted invariant Vα6 T cells are critical stimulators of early innate anti-viral immunity in the amphibian Xenopus. (#42)
5:00 PM
Difluoro substituted CD1d ligands as optimal adjuvants for the priming of multifunctional CD4 T cells. (#43)
5:15 PM